Condition
HPV-Related Anal Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 HPV-Related Anal Squamous Cell Carcinoma clinical trials that are recruiting, at sites in 3 countries (most in United States (4), Brazil (1), Canada (1)). By phase: Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest HPV-Related Anal Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Blood ctDNA testing to guide follow-up and treatment for HPV-related cervical and anal canal cancers. | Phase 2 | São Paulo | Recruiting | Oct 15, 2024 |
| Screening methods for high-risk anal cancer patients | — | Miami, Florida and 3 other locations | Recruiting | Oct 8, 2024 |
| Immunotherapy using E7 TCR-T cells for HPV-related cancers | Phase 2 | Bethesda, Maryland and 2 other locations | Recruiting | Jan 17, 2023 |
| E7 T-cell therapy for advanced HPV-related cancers | Phase 1/2 | New Brunswick, New Jersey and 1 other locations | Recruiting | Dec 7, 2022 |
| Finding HPV DNA in the blood of people with anal or cervical cancer. | — | Chicago, Illinois and 1 other locations | Recruiting | Apr 23, 2021 |
| Screening for anal cancer in women with vulvar lesions | — | Toronto, Ontario | Recruiting | Feb 23, 2017 |
All recruiting trials (6)
-
Blood ctDNA testing to guide follow-up and treatment for HPV-related cervical and anal canal cancers.
This study will test whether regular blood tests for HPV ctDNA can guide follow-up and whether giving pembrolizumab after radiotherapy helps people with HPV-related cervical or anal canal cancer who still have positive ctDNA.
-
Screening methods for high-risk anal cancer patients
This study is testing new ways to screen for early signs of anal cancer in high-risk people, especially those living with HIV, to help improve their health outcomes.
-
Immunotherapy using E7 TCR-T cells for HPV-related cancers
This study is testing a new immunotherapy using E7 TCR-T cells to see if it can help people with advanced HPV-related cancers like cervical and throat cancer feel better and improve their health.
-
E7 T-cell therapy for advanced HPV-related cancers
This study is testing a new treatment using specially modified immune cells to see if it can help people with advanced cancers linked to HPV feel better and live longer.
-
Finding HPV DNA in the blood of people with anal or cervical cancer.
This study will test whether a blood test can find HPV DNA in people with HPV-related anal or cervical cancer before, during, and after radiation treatment.
-
Screening for anal cancer in women with vulvar lesions
This study is testing if screening for anal cancer with Pap smears can help women over 40 who have vulvar lesions catch any problems early and improve their health.
Related topics
Quick answers
How many HPV-Related Anal Squamous Cell Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (4 trials), Brazil (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.